Charles J. Homcy, Director at PORTOLA PHARMACEUTICALS INC (PTLA), sold 50,000 shares at $48.00 ($2.4M) on 2015-07-13, disclosed to the SEC on 2015-07-14.
Scheduled sale ($2.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BBIO | SELL | 2020-10-01 | $380K | — | Filing → |
| BBIO | SELL | 2020-09-29 | $6.7M | — | Filing → |
| BBIO | SELL | 2020-02-12 | $720K | — | Filing → |